Login / Signup

Even after SARS-CoV-2 Booster There is Increased COVID-19 Breakthrough Infection in Patients with Plasma Cell Disorders.

Nathanael R FillmoreJennifer LaJulie Tsu-Yu WuJune K CorriganWestyn Branch-EllimanPaul MonachMary T BrophyNhan V DoNikhil C Munshi
Published in: Blood advances (2023)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • single cell
  • cell therapy
  • mesenchymal stem cells
  • bone marrow